In a model of direct glucose delivery to the hindgut, the length of foregut bypassed directly correlated with degree of GLP-1 increase and ghrelin decrease.Amplify’d from bariatrictimes.comIn a model of direct glucose delivery to the hindgut, the length of foregut bypassed directly correlated with degree of GLP-1 increase and ghrelin decrease.Many diet modifications and metabolic … Continue reading More Bypass => More Satiety => Less Food Intake
The satiety hormone peptide YY as a regulator of appetite. More PYY => Less Food Eaten New study Lap band => DECREASE in PYY => May drive patients to try to eat more!!! PYY reduction in obese subjects is associated with decreased satiety and increased food intake. Obese subjects have a PYY deficiency that reduces … Continue reading New study Lap band => DECREASE in PYY => May drive patients to try to eat more!!!
Slower Transit Time = Greater AbsorbtionAmplify’d from http://www.ncbi.nlm.nih.govDig Dis Sci. 1995 May;40(5):1024-34.Effects of enteral feedback inhibition on motility, luminal flow, and absorption of nutrients in proximal gut of minipigs.Huge A, Weber E, Ehrlein HJ.SourceInstitute of Zoophysiology, University of Hohenheim, Stuttgart, Germany.AbstractWe wanted to clarify whether the postprandial intestinal feedback control activated by nutrients in the … Continue reading Slower Transit Time = Greater Absorbtion
Dietary fibers affect stool weight and transit time.Amplify’d from http://www.ncbi.nlm.nih.govUse of fiber instead of laxative treatment in a geriatric hospital to improve the wellbeing of seniors.Sturtzel B, Mikulits C, Gisinger C, Elmadfa I.SourceDepartment of Nutritional Science, University of Vienna, Vienna, Austria.AbstractINTRODUCTION: Constipation is a common problem in the elderly population, especially in geriatric wards. Laxatives … Continue reading Dietary fibers affect stool weight and transit time.
Wireless motility device (SmartPill®) for the measurement of gastrointestinal transit timeAmplify’d from http://www.ncbi.nlm.nih.govBr J Nutr. 2011 May;105(9):1337-42. Epub 2010 Dec 8.The use of a wireless motility device (SmartPill®) for the measurement of gastrointestinal transit time after a dietary fibre intervention.Timm D, Willis H, Thomas W, Sanders L, Boileau T, Slavin J.SourceDepartment of Food Science and … Continue reading SmartPill® for the measurement of gastrointestinal transit time
Narcotics increase Transit TimeAmplify’d from http://www.ncbi.nlm.nih.govClin Pharmacol Ther. 1997 Apr;61(4):467-75.The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time.Yuan CS, Foss JF, Osinski J, Toledano A, Roizen MF, Moss J.SourceDepartment of Anesthesia and Critical Care, University of Chicago, IL 60637, USA. email@example.comAbstractMethylnaltrexone is a quaternary opioid antagonist with limited ability … Continue reading Narcotics increase Transit Time
Beware Bowel Obstruction After RNYAmplify’d from http://www.ncbi.nlm.nih.govSmall Bowel Obstruction After Antecolic Antegastric Laparoscopic Roux-en-Y Gastric Bypass Without Division of Small Bowel Mesentery: A Single-Centre, 7-Year Review.Reported incidence of small bowel obstruction (SBO) after laparoscopic Roux-en-Y gastric bypass varies between 1.5% and 3.5%. It has been suggested that the antecolic antegastric laparoscopic Roux-en-Y gastric bypass (AA-LRYGB) … Continue reading Beware Bowel Obstruction After RNY
Upper Gastrointestinal Symtoms (UGS) is a reason for discontinuation in patients treated by Low Dose Aspirin (LDA). Fifteen percent of patients treated with Low Dose Aspirin suffered Upper Gastrointestinal Symptoms, mostly Gastroesophageal reflux symptoms which had a negative impact on daily life in 3 out of 4 patients and on treatment compliance in 1 out … Continue reading 15% Low Dose Aspirin suffer Upper Gastrointestinal Symptoms
Gastroduodenal ulcers/erosions were observed in about one-third of asymptomatic patients taking low-dose aspirinAmplify’d from http://www.ncbi.nlm.nih.govQJM. 2011 Feb;104(2):133-9. Epub 2010 Sep 24.Prevalence and independent factors for gastroduodenal ulcers/erosions in asymptomatic patients taking low-dose aspirin and gastroprotective agents: the OITA-GF study.Tamura A, Murakami K, Kadota J; OITA-GF Study Investigators.Collaborators (24)Goto Y, Kawano Y, Naono S, Sato T, … Continue reading Ulcers in about one-third low-dose aspirin patients
Low doses of aspirin increase chance of developing ulcers Aspirin has long been hailed as one of the most effective, low-cost ways to help guard against a heart attack or stroke. However, international medical researchers caution that low doses of aspirin also increase a patient's chance of developing an ulcer, often without warning signs. The … Continue reading Low doses of aspirin increase chance of developing ulcers